• December 7, 2007

    Japan FTC To Penalize Hose Makers For Cartel

    Following an investigation that started in May, the Japan Fair Trade Commission on Friday decided to issue a cease-and-desist order against five marine hose manufacturers for fixing prices on marine hoses, which are used to load and unload oil from tankers.

  • December 10, 2007

    Geico Faces Class Action Over Auto Payments

    Geico General Insurance Co. and its subsidiaries are facing a class action for allegedly cheating customers out of full reimbursement for automobile repairs by paying reduced prices for replacement parts.

  • December 6, 2007

    Judge Throws Out Suit Against Winn-Dixie Execs

    A putative class action against three former Winn-Dixie Stores Inc. executives was tossed Wednesday, with a federal judge finding that statements the defendants made about their new business strategy are not actionable under federal securities laws.

  • December 6, 2007

    Samsung, Nokia Sued Over Four Cell Phone Patents

    A Florida-based patent-holding company has filed suit against cellular phone giants Samsung Electronics Co. Ltd. and Nokia Corp., claiming the companies’ phones infringe four of its patents.

  • December 6, 2007

    Embattled Online Patent Asserted Against 16 Cos.

    A patent-holding company that endured a seven-year re-examination process to affirm an allegedly crucial downloading patent for Web sites has now emerged from its legal hibernation to assert infringement claims against 16 companies.

  • December 5, 2007

    Novartis' Anti-Seizure Drug New Target Of PL Suit

    Already besieged by hundreds of product liability suits surrounding its contentious bone density drugs, Novartis Pharmaceuticals Corp. is now facing a fresh assault over anti-seizure medication Trileptal.

  • December 4, 2007

    Biovail Settles Cardizem Suit With Watson Unit

    A Biovail Corp. subsidiary has agreed to grant generics manufacturer Andrx Pharmaceuticals LLC an exclusive patent license to manufacture Biovail's popular hypertension drug Cardizem in exchange for an undisclosed royalty, bringing Biovail's infringement suit to a close, both companies announced Tuesday.

  • December 4, 2007

    BofA's "Keep The Change" Triggers More Litigation

    Just after it was tossed from one patent suit over its "Keep the Change" program, Bank of America NA was sued by a different inventor Monday over a different patent.

  • December 4, 2007

    Judge OKs Ford’s Deal Over SUV Rollovers

    A California judge has reportedly tentatively signed off on Ford Motor Co.’s bid to settle class action litigation on behalf of nearly one million consumers whose Ford Explorers lost economic value because of their perceived rollover danger.

  • December 3, 2007

    HomeBanc Hit With Securities Class Action

    A purchaser of HomeBanc Mortgage Corp.'s series A stock has alleged that, in the run-up to its offering, the bankrupt lender failed to disclose numerous adverse business circumstances as well as its plans to unload its high-quality loans in favor of subprime ones.

  • December 3, 2007

    Court Won't Stay Generic Approval Of HDI Body Oil

    Dermatological products manufacturer Hill Dermaceuticals Inc. has come up short in its bid for a stay to prevent the U.S. Food & Drug Administration from approving any generic version of its brand-name scalp and body oil until the agency fully responds to its citizen petition.

  • December 3, 2007

    Greenberg Traurig Tabs Soriano To Boost Fla. Practice

    A restructuring lawyer who started Shutts & Bowen LLP's bankruptcy practice in the Tampa Bay, Fla., has been tapped to do the same for Greenberg Traurig LLP in the burgeoning Florida real estate area.

  • December 3, 2007

    Tug-Of-War Over Fosamax Class Continues

    The battle over whether to certify a dental monitoring class in the Fosamax case took center stage on Friday as plaintiffs' attorneys pushed the judge to grant class status to those patients who have yet to develop the painful jaw condition that is allegedly linked to the osteoporosis medication.

  • December 3, 2007

    Alltel Vows To Seek Sanctions Against Speedus

    Alltel Corp. will pursue sanctions against rival wireless company Speedus Corp. for filing a lawsuit over two patents related to wireless transmission technology that Alltel says is frivolous, according to one of Alltel's lawyers.

  • November 30, 2007

    USAA Denies FLSA Allegations

    The United Services Automobile Association has responded to allegations that it has unlawfully denied its special investigators overtime pay, saying it acted in good faith and never intended to violate the law.

  • November 30, 2007

    Mouse Tech Co. Takes Second Swing At Google Earth

    Two months after its lawsuit against Google Inc. was dismissed from a district court in Florida, F&G Research Inc. has filed a new action in North Carolina over the same patent, alleging that Google Earth's controls infringe its intellectual property.

  • November 30, 2007

    Military Contractor Pleads Guilty To Bid-Rigging

    A Florida company will pay $150,000 to settle allegations that it conspired to rig bids on U.S. Navy contracts for assemblies used to transport munitions.

  • November 29, 2007

    Florida Firm Snaps Up Former Regulator

    Florida law firm Fowler White Boggs Banke has snapped up a former regulator for its securities and financial services practice, adding former senior Florida Office of Financial Regulation attorney R. Michael Underwood to its Tallahassee office.

  • November 29, 2007

    AstraZeneca Loses Bid To Toss Strict Liability Claims

    Pharmaceutical company AstraZeneca has lost a battle to toss strict liability claims from the consolidated cases of thousands of Seroquel users who claim they developed diabetes after taking the anti-psychotic drug.

  • November 28, 2007

    Schering Sues Another Generics Co. Over Clarinex

    Schering Corp. has added generics maker Anchen Pharmaceuticals Inc. to the long list of companies it is targeting for patent infringement to protect its hold on the $722 million annual market for allergy treatment Clarinex.